The APOE polymorphisms (APOE4) were confirmed to be significantly associated with AD (p < 0.001) (Table 1, Table S1), although no significant associations were found with BDNF levels or with clinical and anamnestic characteristics. The gene discussed is BDNF; the disease is Alzheimer disease.